PM
CLOV icon

Parametrica Management’s Clover Health Investments CLOV Stock Holding History

Parametrica Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,627
Closed -$34K – 33
2022
Q4 		$34K Buy
36,627
+12,935
+55% +$17.3K 0.07% 42
2022
Q3 		$40K Sell
23,692
-16,918
-42% -$44.3K 0.08% 60
2022
Q2 		$87K Buy
+40,610
New +$108K 0.09% 152
2022
Q1 		– Sell
-11,477
Closed -$43K – 236
2021
Q4 		$43K Buy
+11,477
New +$70.4K 0.04% 56

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Parametrica Management's CLOV Position: Q1 2023 in Review

Parametrica Management sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 36,627 shares — an estimated $34K sold.

Parametrica Management first reported a position in CLOV in Q4 2021 and held it in 4 quarters. The position peaked at $87K in Q2 2022. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • Parametrica Management reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • Parametrica Management sold 36,627 Clover Health Investments shares in Q1 2023, an estimated $34K.
  • Parametrica Management first reported a position in Clover Health Investments in Q4 2021 and held it in 4 quarters.
  • Parametrica Management's Clover Health Investments position peaked at $87K in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on Parametrica Management's 13F filing for Q1 2023, filed 9 May 2023.